•Q4 operating cash inflow was $1.4m up 481% on same quarter prior year
• Revenue of $1.43 million, an increase of 12% on the March 2017 quarter ($1.27m) and 367% ahead of the June 2016 quarter
• FY17 total operating cash inflow was $5.02m ($5.5m including R&D Rebate) and FY17 Operating revenue totalled $4.24m (excludes R&D Rebate), 210% higher than FY16
• Positive operational performance and growth across key metrics: o Over 830,000 users on the MedAdvisor platform, an increase of 17% on the March 2017 quarter o Expanded the MedAdvisor Pharmacy Network, to over 2,600+, with MedAdvisor now providing its platform to all of Discount Drug Stores (DDS) nationwide
• Dr David Chatterton (ex Aconex Ltd CTO – ASX:ACX) appointed Chief Technology Officer ahead of next phase of growth • New pharmacy software platform developed “PlusOne” that will provide additional pharmacy services and expand revenue opportunities for MedAdvisor and network pharmacy customers
- Forums
- ASX - By Stock
- Ann: MDR Jun-17 Quarterly Report & 4C
•Q4 operating cash inflow was $1.4m up 481% on same quarter...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $192.9M |
Open | High | Low | Value | Volume |
35.0¢ | 35.0¢ | 33.0¢ | $1.171M | 3.445M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8200 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 10416 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8200 | 0.340 |
2 | 16427 | 0.335 |
2 | 102909 | 0.330 |
1 | 100000 | 0.325 |
3 | 81349 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 10416 | 1 |
0.360 | 24455 | 1 |
0.380 | 50000 | 1 |
0.385 | 100000 | 1 |
0.390 | 54500 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |